Print Page   |   Contact Us   |   Sign In
Site Search

Annual Member Meeting Sponsors

Advocacy Overview
Public policy plays a critical role in the success of the bioscience industry. BioForward works actively to: 
  • Help shape state and federal policy
  • Be a positive voice that works to educate our legislators and the public on critical bioscience issues
  • Educate our members on public policy issues, and on how they can make their own voice heard
  • Monitor legislation and make our members aware of legislation that will affect their companies and our industry 

  

 

 

January 14th, 2016 Update on AB 305 / SB 260

BioForward and our member companies support and value the ongoing development of lifesaving research at UW-Madison, the Medical College of Wisconsin, and other institutions across our state. Our companies are the link between academic research and the therapies that are available to patients and families struggling with health issues or injuries. Accordingly, we are working with our colleagues from these research institutions and the Wisconsin Legislature to protect research in Wisconsin that utilizes fetal tissue.

Under currently proposed legislation, in the State of Wisconsin, it would be a felony to use ANY fetal cells, fetal cell lines, or fetal tissues for research under all circumstances if those cells were obtained after January 1, 2015.

The sale of fetal tissue is already illegal under federal law. We strongly support that prohibition and our research institutions abide by that prohibition. The bills currently being considered, AB 305/SB 260, go much further. If this legislation passes, we are closing the door on any future research that would be used to develop vaccines, therapies, and other medical innovations.

For more information about this legislation and the Cures for Tomorrow coalition fighting to preserve research in Wisconsin, go to www.curesfortomorrow.org.

Recent Updates:

December 2015

Support swells for vital university research using fetal tissue and cells

AdvaMed, MITA & MDMA Applaud Congress for Passage of the Medical Device Tax Suspension

September 2015

BioForward Response to AB 305
BIO Response to Wisconsin Assembly Bill 305
Launch of Wisconsin Economic Development Report

July 2015

BIOFORWARD FEDERAL CALL TO ACTION: Protect Innovation – Repeal the Medical Device Excise Tax